Title:
ANTI-HUMAN CD22 MONOCLONAL ANTIBODIES AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/152282
Kind Code:
A1
Abstract:
CD22 antibodies, a preparation method therefor, and an application thereof. The CD22 antibodies have a high affinity to CD22 protein. Therefore, the CD22 antibodies can be used in the preparation of drugs for the treatment of diseases such as tumors and autoimmune diseases.
Inventors:
WANG QIONG (CN)
YANG CUIQING (CN)
CAO ZHUOXIAO (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
YANG CUIQING (CN)
CAO ZHUOXIAO (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
Application Number:
PCT/CN2022/072234
Publication Date:
July 21, 2022
Filing Date:
January 17, 2022
Export Citation:
Assignee:
JIANGSU SIMCERE PHARM CO LTD (CN)
International Classes:
A61P35/00; A61K38/00; A61P7/00; C07K16/28; C12N15/13
Domestic Patent References:
WO2000067795A1 | 2000-11-16 |
Foreign References:
CN106029098A | 2016-10-12 | |||
CN103214578A | 2013-07-24 | |||
CN109970858A | 2019-07-05 | |||
CN103588882A | 2014-02-19 | |||
US20130142787A1 | 2013-06-06 | |||
CN109476747A | 2019-03-15 | |||
US20150239974A1 | 2015-08-27 |
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF:
Previous Patent: WAVELENGTH CONVERSION DEVICE AND MANUFACTURING METHOD THEREFOR
Next Patent: LOCAL PATH PLANNING METHOD FOR UNMANNED VEHICLE
Next Patent: LOCAL PATH PLANNING METHOD FOR UNMANNED VEHICLE